Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | FLT3 |
Variant | F621L |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | FLT3 F621L lies within the protein kinase domain of the Flt3 protein (UniProt.org). F621L has been identified in the scientific literature (PMID: 22858906), but has not been biochemically characterized and therefore, its effect on Flt3 protein function is unknown (PubMed, Apr 2024). |
Associated Drug Resistance | Y |
Category Variants Paths |
FLT3 mutant FLT3 exon15 FLT3 F621L |
Transcript | NM_004119.3 |
gDNA | chr13:g.28033968A>G |
cDNA | c.1861T>C |
Protein | p.F621L |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_004119 | chr13:g.28033968A>G | c.1861T>C | p.F621L | RefSeq | GRCh38/hg38 |
NM_004119.3 | chr13:g.28033968A>G | c.1861T>C | p.F621L | RefSeq | GRCh38/hg38 |
NM_004119.2 | chr13:g.28033968A>G | c.1861T>C | p.F621L | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|